drug · small molecule
vicadrostat
Phase 3updated 3mo agoby Boehringer Ingelheim International GmbH🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 1.
all catalysts(0)
nothing on the calendar yet
Trials studying vicadrostat
- phase3A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- phase1A Study in Healthy People to Test How Vicadrostat Affects the Heart
- phase2A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
- phase3A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- phase3EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- phase2Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
- phase1A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood
- phase1A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that